Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence HolderTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
TABLET, FILM COATED
ORAL
Medical Information
L02BX03
abiraterone
Manufacturer Information
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
TEVA Pharmaceutical Industries Ltd.
Active Ingredients
Documents
Package Inserts
Abiraterone-TEVA FC Tablet 250mg PI.pdf
Approved: January 8, 2022